Glenmede Trust’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,570
| Closed | -$232K | – | 1418 |
|
|
2024
Q4 | $232K | Buy |
+5,570
| New | +$232K | ﹤0.01% | 1191 |
|
|
2024
Q3 | – | Sell |
-3,463
| Closed | -$411K | – | 1415 |
|
|
2024
Q2 | $411K | Buy |
3,463
+471
| +16% | +$55.9K | ﹤0.01% | 971 |
|
|
2024
Q1 | $319K | Buy |
+2,992
| New | +$319K | ﹤0.01% | 1043 |
|
|
2023
Q3 | – | Sell |
-3,184
| Closed | -$489K | – | 1333 |
|
|
2023
Q2 | $489K | Hold |
3,184
| – | – | ﹤0.01% | 838 |
|
|
2023
Q1 | $489K | Sell |
3,184
-397
| -11% | -$61K | ﹤0.01% | 842 |
|
|
2022
Q4 | $643K | Buy |
3,581
+1,444
| +68% | +$259K | ﹤0.01% | 767 |
|
|
2022
Q3 | $252K | Buy |
2,137
+181
| +9% | +$21.3K | ﹤0.01% | 1016 |
|
|
2022
Q2 | $278K | Buy |
1,956
+27
| +1% | +$3.84K | ﹤0.01% | 1020 |
|
|
2022
Q1 | $331K | Sell |
1,929
-752
| -28% | -$129K | ﹤0.01% | 1008 |
|
|
2021
Q4 | $680K | Sell |
2,681
-323
| -11% | -$81.9K | ﹤0.01% | 841 |
|
|
2021
Q3 | $1.16M | Buy |
3,004
+1,216
| +68% | +$468K | 0.01% | 663 |
|
|
2021
Q2 | $419K | Sell |
1,788
-2,050
| -53% | -$480K | ﹤0.01% | 931 |
|
|
2021
Q1 | $501K | Buy |
+3,838
| New | +$501K | ﹤0.01% | 847 |
|
|
2020
Q4 | – | Sell |
-1,641
| Closed | -$115K | – | 1834 |
|
|
2020
Q3 | $115K | Sell |
1,641
-96
| -6% | -$6.73K | ﹤0.01% | 1134 |
|
|
2020
Q2 | $111K | Sell |
1,737
-4,263
| -71% | -$272K | ﹤0.01% | 1130 |
|
|
2020
Q1 | $117K | Hold |
6,000
| – | – | ﹤0.01% | 1367 |
|
|
2019
Q4 | $117K | Hold |
6,000
| – | – | ﹤0.01% | 1367 |
|
|
2019
Q3 | $95 | Buy |
6,000
+3,000
| +100% | +$47 | ﹤0.01% | 1424 |
|
|
2019
Q2 | $43 | Hold |
3,000
| – | – | ﹤0.01% | 1751 |
|
|
2019
Q1 | $61 | Buy |
+3,000
| New | +$61 | ﹤0.01% | 1591 |
|